Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTBK
1376
DELISTED
Heritage Commerce
HTBK
| $8.18M | 0.01% |
580,200
-100,800
| -15% | -$1.41M |
|
1377
Signet Jewelers
SIG
$3.62B
| $8.17M | 0.01% |
+118,000
| New | +$8.82M |
|
1378
Dawson Geophysical
DWSN
$139M
| $8.16M | 0.01% |
1,540,814
+44,940
| +3% | +$310K |
|
|
AIQ
1379
DELISTED
Alliance Healthcare Services
AIQ
| $8.15M | 0.01% |
795,460
+32,500
| +4% | +$325K |
|
|
GRP.U
1380
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $8.14M | 0.01% |
232,600
-70,700
| -23% | -$2.41M |
|
|
SYNH
1381
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $8.13M | 0.01% |
177,400
-100,414
| -36% | -$5M |
|
1382
Goldgroup Mining Inc.
GORO
$210M
| $8.13M | 0.01% |
1,798,300
-309,400
| -15% | -$1.59M |
|
1383
Old Second Bancorp
OSBC
$1.31B
| $8.11M | 0.01% |
721,200
+54,900
| +8% | +$591K |
|
1384
Open Text
OTEX
$6.04B
| $8.1M | 0.01% |
238,116
-298,300
| -56% | -$9.92M |
|
|
BFIN
1385
DELISTED
BankFinancial
BFIN
| $8.05M | 0.01% |
554,300
-33,500
| -6% | -$484K |
|
|
CDR
1386
DELISTED
Cedar Realty Trust, Inc
CDR
| $8.02M | 0.01% |
242,061
-49,772
| -17% | -$1.91M |
|
1387
IES Holdings
IESC
$15B
| $8.01M | 0.01% |
442,632
-7,700
| -2% | -$148K |
|
|
OKSB
1388
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $8M | 0.01% |
305,933
+16,292
| +6% | +$446K |
|
|
EXFO
1389
DELISTED
EXFO INC.
EXFO
| $8M | 0.01% |
1,537,890
+162,510
| +12% | +$874K |
|
|
BGC
1390
DELISTED
General Cable Corporation
BGC
| $8M | 0.01% |
445,500
+64,700
| +17% | +$1.16M |
|
|
PRTK
1391
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $7.98M | 0.01% |
414,513
+304,249
| +276% | +$4.79M |
|
1392
Yum China
YUMC
$16.1B
| $7.97M | 0.01% |
+293,100
| New | +$7.84M |
|
1393
Bank of Marin Bancorp
BMRC
$462M
| $7.97M | 0.01% |
247,600
+14,560
| +6% | +$495K |
|
1394
Acco Brands
ACCO
$400M
| $7.96M | 0.01% |
605,147
+149,800
| +33% | +$1.95M |
|
|
HT
1395
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $7.95M | 0.01% |
423,025
-216,800
| -34% | -$4.35M |
|
1396
Suncor Energy
SU
$76.5B
| $7.95M | 0.01% |
258,540
+226,000
| +695% | +$7.12M |
|
|
MDCO
1397
DELISTED
Medicines Co
MDCO
| $7.94M | 0.01% |
162,332
-253,568
| -61% | -$11.6M |
|
|
WBT
1398
DELISTED
Welbilt, Inc.
WBT
| $7.92M | 0.01% |
403,500
-81,600
| -17% | -$1.56M |
|
1399
Granite Construction
GVA
$5.41B
| $7.92M | 0.01% |
157,800
-27,100
| -15% | -$1.44M |
|
|
DSPG
1400
DELISTED
DSP Group Inc
DSPG
| $7.92M | 0.01% |
660,000
-69,353
| -10% | -$769K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.